Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.66 USD | +0.37% | -6.16% | +131.86% |
12/06 | Vera Therapeutics, Inc. Appoints Christy Oliger to the Board | CI |
28/05 | Vera Therapeutics Gets FDA Breakthrough Therapy Designation for Immunoglobulin A Nephropathy Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+131.86% | 1.94B | |
+35.14% | 51.07B | |
-7.43% | 38.78B | |
+35.88% | 38.61B | |
-10.62% | 27.32B | |
+11.63% | 26.35B | |
-17.77% | 19.46B | |
+40.52% | 13.58B | |
+30.70% | 12.46B | |
-3.41% | 11.75B |
- Stock Market
- Equities
- VERA Stock
- News Vera Therapeutics, Inc.
- Guggenheim Initiates Vera Therapeutics With Buy Rating, $27 Price Target